<VariationArchive VariationID="11448" VariationName="NM_001099857.5(IKBKG):c.1110dup (p.Ala371fs)" VariationType="Duplication" Accession="VCV000011448" Version="4" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-07-29" DateCreated="2017-09-19" MostRecentSubmission="2024-07-29">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="26487" VariationID="11448">
      <GeneList>
        <Gene Symbol="IKBKG" FullName="inhibitor of nuclear factor kappa B kinase regulatory subunit gamma" GeneID="8517" HGNC_ID="HGNC:5961" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="154541238" stop="154565046" display_start="154541238" display_stop="154565046" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153770458" stop="153793260" display_start="153770458" display_stop="153793260" Strand="+" />
          </Location>
          <OMIM>300248</OMIM>
          <Haploinsufficiency last_evaluated="2020-11-10" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=IKBKG">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-11-10" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=IKBKG">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_001099857.5(IKBKG):c.1110dup (p.Ala371fs)</Name>
      <CanonicalSPDI>NC_000023.11:154564007:CCCCCC:CCCCCCC</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>Xq28</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="154564007" stop="154564008" display_start="154564007" display_stop="154564008" variantLength="1" positionVCF="154564007" referenceAlleleVCF="G" alternateAlleleVCF="GC" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153792222" stop="153792223" display_start="153792222" display_stop="153792223" variantLength="1" positionVCF="153792222" referenceAlleleVCF="G" alternateAlleleVCF="GC" />
      </Location>
      <ProteinChange>A439fs</ProteinChange>
      <ProteinChange>A272fs</ProteinChange>
      <ProteinChange>A370fs</ProteinChange>
      <ProteinChange>A371fs</ProteinChange>
      <ProteinChange>A248fs</ProteinChange>
      <ProteinChange>A319fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001099857.2" sequenceAccession="NM_001099857" sequenceVersion="2" change="c.1110dupC">
            <Expression>NM_001099857.2:c.1110dupC</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.153792228dup" Assembly="GRCh37">
            <Expression>NC_000023.10:g.153792228dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.154564013dup" Assembly="GRCh38">
            <Expression>NC_000023.11:g.154564013dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009896.1" sequenceAccession="NG_009896" sequenceVersion="1" change="g.26770dup">
            <Expression>NG_009896.1:g.26770dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001099856.6" sequenceAccession="NM_001099856" sequenceVersion="6" change="c.1314dup">
            <Expression>NM_001099856.6:c.1314dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001093326.2" sequenceAccession="NP_001093326" sequenceVersion="2" change="p.Ala439fs">
            <Expression>NP_001093326.2:p.Ala439fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001099857.5" sequenceAccession="NM_001099857" sequenceVersion="5" change="c.1110dup" MANESelect="true">
            <Expression>NM_001099857.5:c.1110dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001093327.1" sequenceAccession="NP_001093327" sequenceVersion="1" change="p.Ala371fs">
            <Expression>NP_001093327.1:p.Ala371fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001145255.4" sequenceAccession="NM_001145255" sequenceVersion="4" change="c.813dup">
            <Expression>NM_001145255.4:c.813dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001138727.1" sequenceAccession="NP_001138727" sequenceVersion="1" change="p.Ala272fs">
            <Expression>NP_001138727.1:p.Ala272fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001321396.3" sequenceAccession="NM_001321396" sequenceVersion="3" change="c.1110dup">
            <Expression>NM_001321396.3:c.1110dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001308325.1" sequenceAccession="NP_001308325" sequenceVersion="1" change="p.Ala371fs">
            <Expression>NP_001308325.1:p.Ala371fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001321397.3" sequenceAccession="NM_001321397" sequenceVersion="3" change="c.1107dup">
            <Expression>NM_001321397.3:c.1107dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001308326.1" sequenceAccession="NP_001308326" sequenceVersion="1" change="p.Ala370fs">
            <Expression>NP_001308326.1:p.Ala370fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001377312.1" sequenceAccession="NM_001377312" sequenceVersion="1" change="c.1110dup">
            <Expression>NM_001377312.1:c.1110dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001364241.1" sequenceAccession="NP_001364241" sequenceVersion="1" change="p.Ala371fs">
            <Expression>NP_001364241.1:p.Ala371fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001377313.1" sequenceAccession="NM_001377313" sequenceVersion="1" change="c.1107dup">
            <Expression>NM_001377313.1:c.1107dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001364242.1" sequenceAccession="NP_001364242" sequenceVersion="1" change="p.Ala370fs">
            <Expression>NP_001364242.1:p.Ala370fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001377314.1" sequenceAccession="NM_001377314" sequenceVersion="1" change="c.954dup">
            <Expression>NM_001377314.1:c.954dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001364243.1" sequenceAccession="NP_001364243" sequenceVersion="1" change="p.Ala319fs">
            <Expression>NP_001364243.1:p.Ala319fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001377315.1" sequenceAccession="NM_001377315" sequenceVersion="1" change="c.741dup">
            <Expression>NM_001377315.1:c.741dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001364244.1" sequenceAccession="NP_001364244" sequenceVersion="1" change="p.Ala248fs">
            <Expression>NP_001364244.1:p.Ala248fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003639.4" sequenceAccession="NM_003639" sequenceVersion="4" change="c.1110dup">
            <Expression>NM_003639.4:c.1110dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_003630.1" sequenceAccession="NP_003630" sequenceVersion="1" change="p.Ala371fs">
            <Expression>NP_003630.1:p.Ala371fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_165197.1" sequenceAccession="NR_165197" sequenceVersion="1" change="n.979dup">
            <Expression>NR_165197.1:n.979dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_70" sequenceAccession="LRG_70">
            <Expression>LRG_70:g.26770dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003639.3" sequenceAccession="NM_003639" sequenceVersion="3" change="c.1110dup">
            <Expression>NM_003639.3:c.1110dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_70t1" sequenceAccession="LRG_70t1">
            <Expression>LRG_70t1:c.1110dup</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="300248.0004" DB="OMIM" />
        <XRef Type="rs" ID="1569556615" DB="dbSNP" />
      </XRefList>
      <Comment DataSource="ClinGen" Type="public">ClinGen staff contributed the HGVS expression for this variant.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001099857.5(IKBKG):c.1110dup (p.Ala371fs) AND Incontinentia pigmenti syndrome" Accession="RCV000012201" Version="16">
        <ClassifiedConditionList TraitSetID="3124">
          <ClassifiedCondition DB="MedGen" ID="C0021171">Incontinentia pigmenti syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2000-05-25" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001099857.5(IKBKG):c.1110dup (p.Ala371fs) AND not provided" Accession="RCV003162240" Version="1">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-04-10" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-04-10" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2017-09-19" MostRecentSubmission="2024-07-29">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10839543</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="3124" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="2304" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Incontinentia pigmenti, familial male-lethal type</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Bloch-Sulzberger syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Incontinentia pigmenti type 2 (formerly)</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">IP2 (formerly)</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Incontinentia pigmenti syndrome</ElementValue>
                <XRef ID="Incontinentia+pigmenti/3798" DB="Genetic Alliance" />
                <XRef ID="367520004" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">INCONTINENTIA PIGMENTI, TYPE II</ElementValue>
                <XRef Type="MIM" ID="308300" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">IP</ElementValue>
                <XRef Type="MIM" ID="308300" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">IP2</ElementValue>
                <XRef Type="MIM" ID="308300" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6778" />
                <XRef ID="6778" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Incontinentia pigmenti (IP) is a disorder that affects the skin, hair, teeth, nails, eyes, and central nervous system; it occurs primarily in females and on occasion in males. Characteristic skin lesions evolve through four stages: I. Blistering (birth to age ~4 months). II. Wart-like rash (for several months). III. Swirling macular hyperpigmentation (age ~6 months into adulthood). IV. Linear hypopigmentation. Alopecia, hypodontia, abnormal tooth shape, and dystrophic nails are observed. Neovascularization of the retina, present in some individuals, predisposes to retinal detachment. Neurologic findings including seizures, intellectual disability, and developmental delays are occasionally seen.</Attribute>
                <XRef ID="NBK1472" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301645</ID>
                <ID Source="BookShelf">NBK1472</ID>
              </Citation>
              <XRef ID="464" DB="Orphanet" />
              <XRef ID="C0021171" DB="MedGen" />
              <XRef ID="MONDO:0010631" DB="MONDO" />
              <XRef Type="MIM" ID="308300" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="32435" SubmissionDate="2017-09-13" DateLastUpdated="2024-07-29" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="300248.0004_INCONTINENTIA PIGMENTI" title="IKBKG, 1-BP INS, 1110C_INCONTINENTIA PIGMENTI" />
        <ClinVarAccession Accession="SCV000032435" DateUpdated="2024-07-29" DateCreated="2013-04-04" Type="SCV" Version="5" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2000-05-25">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a family with incontinentia pigmenti (IP; 308300), The International Incontinentia Pigmenti Consortium (2000) identified a single C insertion between nucleotides 1110 and 1111 that segregated with the disease. This frameshift mutation would putatively append 23 new amino acids onto proline residue 370 in the translated protein.</Attribute>
              <Citation>
                <ID Source="PubMed">10839543</ID>
              </Citation>
              <XRef DB="OMIM" ID="308300" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="IKBKG" />
          </GeneList>
          <Name>IKBKG, 1-BP INS, 1110C</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP INS, 1110C</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="300248.0004" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">INCONTINENTIA PIGMENTI</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7258818" SubmissionDate="2023-04-12" DateLastUpdated="2023-04-15" DateCreated="2023-04-15">
        <ClinVarSubmissionID localKey="GDXSV:266929" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV003915107" DateUpdated="2023-04-15" DateCreated="2023-04-15" Type="SCV" Version="1" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-04-10">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Frameshift variant predicted to result in protein truncation, as the last 49 amino acids are replaced with 23 different amino acids, and other loss-of-function variants have been reported downstream (HGMD; Ohnishi et al., 2017; Kawai et al., 2012; Aradhya et al., 2001); No data available from control populations to assess the frequency of this variant; This variant is associated with the following publications: (PMID: 28702714, 22517901, 11179023, 24339369, 10839543, 18350553)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="IKBKG" />
          </GeneList>
          <VariantType>Duplication</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:26708</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_003639.3:c.1110dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_175_20230412054203</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7258818" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="32435" TraitType="Disease" MappingType="Name" MappingValue="INCONTINENTIA PIGMENTI" MappingRef="Preferred">
        <MedGen CUI="C0021171" Name="Incontinentia pigmenti syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>